Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Lung Neoplasms 18Breast Neoplasms 16Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 9Prostatic Neoplasms 8Pancreatic Neoplasms 8Neoplasms 8Hematopoietic and Lymphatic System Neoplasm 7Hematologic Neoplasms 7Anatomic Stage I Breast Cancer AJCC v8 7Ovarian Neoplasms 5Breast Carcinoma In Situ 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Neoplasm Metastasis 4Multiple Myeloma 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Neoplasms 4Head and Neck Carcinoma 4Carcinoma, Renal Cell 4Squamous Cell Carcinoma of Head and Neck 3Malignant Solid Neoplasm 3Esophageal Neoplasms 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Salpingo-oophorectomy 2Genetic Testing 2Genetic Counseling 2Diet, Mediterranean 2Videotape Recording 1Telemedicine 1Standard of Care 1Specimen Handling 1Salpingectomy 1Practice Guidelines as Topic 1Ovariectomy 1Methods 1Genotype 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hereditary Breast and Ovarian Cancer Syndrome × Practice Guidelines as Topic × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡